16 / 1023
Symposium
New concepts of tumour radioresistance (Abs. 575-577)
Symposium with Proffered Papers
Towards Personalised Radiation Oncology (PRO) (Abs. 578-582)
Symposium
The tumour in 3D: the role of tumour microenvironment (Abs. 583-586)
WBRT for brain metastases- the end of an era? (Abs. 587-589)
Radiotherapy "autovaccination" with systemic immune
modulators for modern immunotherapy (Abs. 590-592)
Joint Symposium
ESTRO-AAPM-EFOMP: Functional / biological imaging and radiotherapy
physicists: new requests/challenges and the need for better and more
specific training (Abs. 593-595)
Symposium
The future of QA lies in automation (Abs. 596-599)
Management and optimisation of the daily workflow (Abs. 600-602)
Combining radiotherapy with molecular targeted agents: learning from
successes and failures (Abs. 603-605)
Symposium with Proffered Papers
Radiomics - the future of radiotherapy? (Abs. 606-609)
Symposium
Radiobiology of proton / carbon / heavy ions (Abs. 610-612)
New insights in treating vertebral metastases (Abs. 613-615)
IMRT, the new standard in treatment of gynaecological, lung and
breast cancers? (Abs. 616-618)